United States · Investor

National Institutes of Health

Last cheque observed Sep 2026; 387 cheques on record.

Deploying nowGovernment

GrantSeedContact ManagementEnterprise SoftwareBiotechnology

Deploying now
60%of best year52cheques in 12 months, 387 on record
Since the last cheque55days00hrs00min00sec
Median round$2.3MRounds led0 of 387Sole investor173 roundsExits2 from the portfolioMostly inUnited States, 98%
Pitch National Institutes of Health

National Institutes of Health highlights

  1. 01

    52 cheques in the last 12 months

  2. 02

    Mostly Grant and Venture: 85% of its rounds

  3. 03

    Sole investor in 173 rounds, median $2.0M

  4. 04

    2 exits from the portfolio

What they do

Type
Government (from a list, unverified)
Cheque size
Not stated
Stages
GrantSeed
Sectors
Contact ManagementEnterprise SoftwareBiotechnology
Based in
Bethesda, United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first387 appearances

  1. 2026

    43 rounds

  2. Sept
    Partillion BioscienceGrant · US$2.1MWith 3 others
  3. Sept
    Stem PharmGrant · US$2.5MWith 2 others
  4. Sept
    HDT BioGrant · US$5.2MWith 1 other
  5. Sept
    Rejuvenation TechnologiesVenture · US$2.0MWith 2 others
  6. Sept
    InformAIGrant · US$1.0MWith 3 others
  7. Sept
    Retham TechnologiesGrant · US$4.8MSole investor
  8. Sept
    Capienda BiotechGrant · US$1.4MWith 1 other
  9. Sept
    PerfusioGrant · US$75KWith 1 other
  10. Sept
    Clene NanomedicineUS$4.0MWith 1 other
  11. Sept
    Airway TherapeuticsGrant · US$1.9MWith 1 other
  12. Aug
    Astrocyte PharmaceuticalsGrant · US$400KWith 2 others
  13. Aug
    CND Life SciencesGrowth · US$14MSole investor
  14. Jul
    Eliaz TherapeuticsCrowdfunding · US$42KSole investor
  15. Jul
    SapphirosGrant · US$12MSole investor
  16. Jul
    Trace BiosciencesSeries A · US$150KWith 1 other
  17. Jul
    EpitelSeries B · US$26MWith 1 other
  18. Jun
    iQure PharmaVenture · USUndisclosedWith 1 other
  19. Jun
    POP BiotechnologiesGrant · US$9.7MWith 1 other
  20. Jun
    BiaCure TherapiesVenture · USUndisclosedSole investor
  21. Jun
    eXoZymesGrant · US$2.0MWith 2 others
  22. Jun
    Fesarius TherapeuticsSeries A · US · Jefferson Life Sciences$20MWith 6 others
  23. May
    Co-DiagnosticsUS$3.0MSole investor
  24. May
    PsileraSeed · US$8.8MSole investor
  25. May
    Quiver BioscienceGrant · US$9.3MWith 1 other
  26. May
    Allyx TherapeuticsSeries B · US$27MWith 1 other
  27. May
    Levisonics IncGrant · US$15KWith 1 other
  28. May
    Virtuoso SurgicalVenture · US$2.9MSole investor
  29. Apr
    AcuraStemGrant · US$7.5MWith 1 other
  30. Apr
    Sparian BiosciencesGrant · US$15MSole investor
  31. Apr
    LUCID DIAGNOSTICS INC.US$18MSole investor
  32. Apr
    Novel MicrodevicesUS$1.0MWith 1 other
  33. Apr
    Transcode TherapeuticsDebt · US$6.0MWith 2 others
  34. Mar
    Myosin TherapeuticsGrant · US$2.0MWith 3 others
  35. Mar
    AmydisGrant · US$2.5MWith 1 other
  36. Mar
    Homecare HubVenture · CAUndisclosedWith 1 other
  37. Mar
    MAIA BiotechnologyUS$30MSole investor
  38. Mar
    AzitraUS$31MWith 3 others
  39. Feb
    BrainCheckSeries A · US · Ventureburn$13MWith 3 others
  40. Feb
    Index HealthTech, LLCGrant · US$10KWith 1 other
  41. Feb
    Perspective TherapeuticsUS$175MWith 2 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 3 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Exits from the portfolio

Companies it backed that were later bought or listed2 in all

Lift LabsBought by GoogleUndisclosedSept 2014
Galectin TherapeuticsListedUndisclosedMar 2012

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as National Institutes of Health. A count of rooms they were both in, not a relationship either has claimed.

Recently backed

The latest companies National Institutes of Health put money into.

Mentioned on podcasts

Episodes that name National Institutes of Health in their description, not their title.

Quick answers about National Institutes of Health

What does National Institutes of Health invest in?

National Institutes of Health invests most often at Grant and Venture (85% of the rounds on record), in sectors such as Contact Management, Enterprise Software and Biotechnology.

How active is National Institutes of Health?

387 investments on record, 52 of them in the last 12 months. The most recent was in Sept 2026.

What has National Institutes of Health invested in recently?

Its most recent investments on record: Partillion Bioscience (Grant, Sept 2026), Stem Pharm (Grant, Sept 2026) and HDT Bio (Grant, Sept 2026).

How big are National Institutes of Health's cheques?

The median round it joins is $2.3M.

Does National Institutes of Health lead rounds?

Rarely, if at all: none of its 387 investments on record names it as the lead.

Where does National Institutes of Health invest?

Most of the companies it backs are in the United States (98%).

Is National Institutes of Health investing now?

Yes: it is actively investing, with 52 investments in the last 12 months.

Who does National Institutes of Health invest alongside?

Most often National Science Foundation (71 rounds together), MassChallenge (18 rounds together) and National Institute of Allergy and Infectious Diseases (12 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it